Jordan R E, Nelson R M, Kilpatrick J, et al. Inactivation of human antithrombin by neutrophil elastase. Kinetics of the heparin dependent reaction [J]. J Biol Chem, 1989, 264(18): 10 493- 10 500.
[2]
Duswald K H, Jochum M, Schramm W, et al. Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery[J]. Surgery, 1985, 98: 892-899.
[3]
Olson S T. Heparin and ionic strength-dependent conversion of antithrombin Ⅲ from an inhibitor to a substrafe of alpha thrombin[J]. J Biol Chem, 1985, 260 10 153 -10 160.
[4]
Mochizuki S, Hamato N, Hirose M, et al. Expression and characterization of recombinant human antithrombin Ⅲ in Pichia pastoris [J]. Protein Expression Purif, 2001, 23:55- 65.
[5]
Gettins P G. Serpin structure, mechanism, and function[J]. ChemRev, 2002, 102:4 251-4 803.
[6]
Kurachi K, Schmer G, Hermodson M Aet al. Characterization of human, bovine, and horse antithrombin Ⅲ[J]. Biochemistry, 1976, 1,5: 368-373.
Doolittle R F. Angiotensinogen is related to the antitrypsin-antithrombin- ovalbumin family [J]. Science, 1983, 222: 417-419.
[9]
Andersen O, Flengsrud R, Norberg K et al. Salmon antithrombin has only three carbohydrate side chains, and shows functional similarities to human β-antithrombin[J]. EurJ Biochem, 2000, 267:1 651 -1 657.
[10]
Backovic M, Gettins P G. Insight into residues critical for abtithrombin function from analysis of an expanded database of sequences that includes frog, turtle, and ostrich antithrombins[J]. J Proteome Res, 2002, 1: 367- 373.
[11]
Frost C L, Naud R J, Muramoto K. Ostrich an tithrombin Ⅲ: kinetics and mechanism of inhibition of ostrich thrombin[J]. J Biol Chem, 2002, 34:1 164-1 171.
[12]
Liang Y, Zhang S, I.un L etal. Presence and localization of antithrombin and its regulation after acute lipopolysaccharide exposure in amphioxus, with implications for the origin of vertebrate liver[J]. Cell Tissue Res, 2006, 323: 537-541.
[13]
Liang Y, Zhang S. Demonstration of plasminogen- like protein in amphioxus with implications for the origin of vertebrate liver[J]. Acta Zoologica, 2006, 87: 141-145.
[14]
Johnson D J D, Li W, Huntington J A, et al. Antithrombin - S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation[J]. EMBOJ, 2006, 25 (9): 2 029 -2 037.
[15]
Abildgaard U. Antithrombin -early prophecies and present challenges [J]. Thromb Haemost, 2007, 98: 97-104.
[16]
Quinsey N S, Greedy A L, Whisstock J C, et al. Antithrombin., in control of coagulation[J]. Int J Biochem Cell Biol, 2004, 36(3): 386-389.
[17]
Seyrek E, Dubin P L, Henriksen J. Non-specific electrostatic binding characteristics of the heparin antithrombin interaction [J]. Biopolymers, 2007, 86: 249 -259.
[18]
Bock S C, Olson S T, Bjork I, et al. Roles of N- terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin induced conformationalchange. Biochemistry, 2004, 43 (3): 675- 683.
[19]
Carrell R, Skinner R, Whisstock J, et al. Antithrom bin and heparin[J]. Mol Med Today, 1995, 1(5): 226 -231.
[20]
Zhou A, Carrell R W, Huntington J A. Thes erpin inhibitory mechanism is critically dependent on the length of the reactive center loop[J]. J Biol Chem, 2001, 276:27 541 -27 547.
[21]
Bock S C, Harris J F, Balazs I, et al. Assignment of the human antithrombin Ⅲ structural gene to chromosome 1q23 -25[J]. Cytogenet Cell Genet, 1985. 37:32 -41.
[22]
Olds R J, Lane D A, Chowdury V, et al. (ATT) Trinucleotlde repeats in the antithrombin gene and their use in determining the origin of repeated mutations[J]. HumMutat, 2005, 4:31- 41.
[23]
Book S C, Levitan D J. Characterization of an unusual DNA length polymorphism 5\\'to the human antithrombin Ⅲ gene[J]. Nucleic Adds Res, 1983, 11(24): 8 569 -8 582.
[24]
Bock S C, Wion K L, Vehar G A, etal. Cloning and expression of the cDNA for human antithrombin Ⅲ [J]. Nucleic Adds Res, 1982, 10:8 113 -8 125.
[25]
Wasley L C, Attra D H, Bauer K A etal. Expression and characterization of human antithrombin Ⅲ synthesized in mammalian cells[J]. J Biol Chem, 1987, 262: 14 766 -14 772.
[26]
Stephens A W, Siddiqui A, Hirs C H W. Expression of functionally active human antithrombin Ⅲ[J]. Proc Natl Acad Sci US A, 1987, 84:3 886- 3 890.
